Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux
Year: 2014
Type: review
Abstract: Hepatic glucose and lipid metabolism are altered in metabolic disease (e.g. obesity, metabolic syndrome, and Type 2 diabetes). Insulin-dependent regulation of glucose metabolism is impaired. In contrast, lipogenesis, hypertriglyceridemia, and hepatic steatosis are increased. Because insulin promotes lipogenesis and liver fat accumulation, to explain the elevation in plasma and tissue lipids, investigators have suggested the presence of pathway-selective insulin resistance. In this model, insulin signaling to glucose metabolism is impaired, but insulin signaling to lipid metabolism is intact. We discuss the evidence for the differential regulation of hepatic lipid and glucose metabolism. We suggest that the primary phenotypic driver is altered substrate delivery to the liver, as well as the repartitioning of hepatic nutrient handling. Specific alterations in insulin signaling serve to amplify the alterations in hepatic substrate metabolism. Thus, hyperinsulinemia and its resultant increased signaling may facilitate lipogenesis, but are not the major drivers of the phenotype of pathway-selective insulin resistance.
Source: Journal of Biological Chemistry
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: Impact of Inflammation on the Control of Muscle Glucose Uptake, G117257630, G1221739687, G1352409854, Nutrition Infection and Hepatic Carbohydrate Metabolism, G3841187713, Vanderbilt Mouse Metabolic Phenotyping Center, G4424950377, G4784588152, G5436572433, Diabetes Research and Training Center, Nutrition Infection and Hepatic Carbohydrate Metabolism, G9000052735, G9000269960, Vanderbilt Diabetes Research Center
OpenAlex ID: W2092608666
